Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 25, 2019
Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in TaiwanFeng-Ming Tien, Cheng-Hong Tsai, Jia-Hau Liu, et al.
Tzu Chi Medical Journal|April 22, 2024
Recent advancements in hematopoietic stem cell transplantation in TaiwanChi-Cheng Li, Xavier Cheng-Hong Tsai, Wei-Han Huang, et al.
Blood|August 30, 2023
TP53 status and impact on AML prognosis within the ELN 2022 risk classificationShaun Fleming, Xavier Cheng-Hong Tsai, Rhiannon Morris, et al.
Clinical and Experimental Medicine|July 10, 2025
Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblingsTyng-Wei Yang, Xavier Cheng-Hong Tsai, Yu-Hsuan Fu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 16, 2020
A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencingWei-Hao Wang, Meng-Yao Lu, Cheng-Hong Tsai, et al.
British Journal of Haematology|September 18, 2021
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndromeYu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, et al.
Clinical Pharmacology and Therapeutics|December 5, 2025
Letermovir Prophylaxis for CMV DNAemia/Disease after HLA-Mismatched HSCT: A Retrospective Real-World Analysis with Overlap Propensity Score WeightingYi-Che Huang, Shu-Wen Lin, Xavier Cheng-Hong Tsai, et al.
Blood Advances|February 21, 2020
A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patientsYu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, et al.
Cancer Medicine|January 5, 2023
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphomaChieh-Lung Cheng, Po-Ting Yeh, Wei-Quan Fang, et al.
Journal of Cancer|March 17, 2025
Both consolidation and maintenance treatment improve outcomes in primary central nervous system lymphoma: real-world evidence from a tertiary medical centerChieh-Lung Cheng, Chang-Tsu Yuan, Wei-Quan Fang, et al.
Pageof 7